ÂÜÀòÂÒÂ×

Bob brings an extensive history of innovation in the cell and gene therapy industry, experience developing and managing global business operations, and leadership honed through driving growth in several regenerative medicine organizations. In 1999, Bob co-founded what is now known as Minaris Regenerative Medicine, formerly Hitachi Chemical Advanced Therapeutics Solutions’ (HCATS, formerly PCT) — the first CDMO exclusively focused on the emerging cell and gene therapy industry. As its president and CEO, he oversaw its successful growth and development strategy over the last two decades. Bob began his career as an educator and has been active in the public health arena. He has served as treasurer and founding member of International Society for Cellular Therapy, director for the Association for the Advancement of Blood & Biotherapies, and chairman for the Alliance for Regenerative Medicine, where he previously served as director, vice chairman, and co-chair of the Standards and Technology Committee. He has published and presented extensively on a variety of topics relating to cellular therapies.